We are live on ! Find out more
WJA

Williams Jones & Associates Portfolio holdings

AUM $4.82B
1-Year Est. Return 19.95%
This Fund
S&P 500
This Quarter Est. Return
+2.97%
1 Year Est. Return
+19.95%
3 Year Est. Return
+72.11%
5 Year Est. Return
+86.19%
10 Year Est. Return
AUM
$3.24B
AUM Growth
+$1.1B
Cap. Flow
+$1.04B
Cap. Flow %
32.2%
Top 10 Hldgs %
24.95%
Holding
434
New
69
Increased
208
Reduced
78
Closed
33

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$26.1M
2
SIG icon
Signet Jewelers
SIG
+$22M
3
GT icon
Goodyear
GT
+$18M
4
BX icon
Blackstone
BX
+$9.22M
5
WSM icon
Williams-Sonoma
WSM
+$7.23M

Sector Composition

Rank Sector Weight
1 Healthcare 18.82%
2 Industrials 13.57%
3 Technology 11.96%
4 Financials 11.11%
5 Communication Services 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
26
ExxonMobil
XOM
$634B
$36.5M 1.12%
389,117
+146,303
+60% +$12.9M
NXPI icon
27
NXP Semiconductors
NXPI
$65.4B
$35.4M 1.09%
452,290
-8,624
-2% -$740K
BMY icon
28
Bristol-Myers Squibb
BMY
$130B
$34.6M 1.07%
470,668
+74,372
+19% +$5.26M
CSCO icon
29
Cisco
CSCO
$456B
$32.1M 0.99%
1,120,052
+237,697
+27% +$6.67M
BRK.B icon
30
Berkshire Hathaway Class B
BRK.B
$1.11T
$30.2M 0.93%
208,616
+186,124
+828% +$26.6M
GOOG icon
31
Alphabet (Google) Class C
GOOG
$4.07T
$30M 0.93%
867,880
+105,200
+14% +$3.78M
GE icon
32
GE Aerospace
GE
$377B
$29.7M 0.91%
196,585
+22,002
+13% +$3.21M
ESRX
33
DELISTED
Express Scripts Holding Company
ESRX
$29.2M 0.9%
384,599
+375,777
+4,260% +$27.6M
CL icon
34
Colgate-Palmolive
CL
$74.2B
$28.3M 0.87%
387,183
+6,641
+2% +$473K
EQM
35
DELISTED
EQM Midstream Partners, LP
EQM
$26.9M 0.83%
334,741
-5,001
-1% -$377K
JPM icon
36
JPMorgan Chase
JPM
$950B
$25.9M 0.8%
417,117
-9,677
-2% -$604K
BX icon
37
Blackstone
BX
$107B
$25.8M 0.8%
1,052,560
-346,777
-25% -$9.22M
AGN
38
DELISTED
Allergan plc
AGN
$25.5M 0.79%
110,544
+1,242
+1% +$286K
MMP
39
DELISTED
Magellan Midstream Partners, L.P.
MMP
$25.5M 0.79%
335,735
-5,900
-2% -$418K
TROW icon
40
T. Rowe Price
TROW
$26.1B
$25.4M 0.78%
348,314
+347,414
+38,602% +$25.9M
MSFT icon
41
Microsoft
MSFT
$2.92T
$25.3M 0.78%
493,602
+334,382
+210% +$17.4M
CELG
42
DELISTED
Celgene Corp
CELG
$24.3M 0.75%
246,141
-53,333
-18% -$5.52M
IBB icon
43
iShares Biotechnology ETF
IBB
$9.55B
$23.8M 0.73%
277,647
+73,287
+36% +$6.58M
PFE icon
44
Pfizer
PFE
$144B
$23.8M 0.73%
711,917
+173,370
+32% +$5.53M
IBM icon
45
IBM
IBM
$214B
$23.5M 0.73%
162,106
+40,775
+34% +$5.84M
CDK
46
DELISTED
CDK Global, Inc.
CDK
$23.3M 0.72%
420,283
+419,068
+34,491% +$21.7M
CVX icon
47
Chevron
CVX
$374B
$23M 0.71%
219,040
+107,345
+96% +$10.8M
WEX icon
48
WEX
WEX
$6.23B
$23M 0.71%
+258,837
New +$23.1M
SLB icon
49
SLB Ltd
SLB
$74.2B
$22.4M 0.69%
283,530
+210,944
+291% +$16.2M
ROK icon
50
Rockwell Automation
ROK
$52.4B
$22.1M 0.68%
192,474
-3,050
-2% -$349K

Similar funds

Williams Jones & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Williams Jones & Associates held 434 positions worth $3.24B, up 51% from $2.15B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Williams Jones & Associates deployed $1.04B of net new capital in Q2 2016, opening 69 new positions and adding to 208 existing holdings. Its largest new stake was Idexx Laboratories: 657,531 shares worth $61.1M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was CVS Health, an estimated $26.1M trimmed.

  • Williams Jones & Associates's largest Q2 2016 buy was Idexx Laboratories: 657,531 shares worth $61.1M.
  • Williams Jones & Associates added most to Visa in Q2 2016, an estimated $85M increase.
  • Williams Jones & Associates's biggest Q2 2016 reduction was CVS Health, cutting an estimated $26.1M.
  • Williams Jones & Associates fully exited Signet Jewelers in Q2 2016, selling an estimated $22M.
  • Williams Jones & Associates's ten largest holdings make up 25% of its $3.24B portfolio in Q2 2016.
  • Williams Jones & Associates opened 69 new positions and closed 33 in Q2 2016.
  • Williams Jones & Associates's portfolio value rose 51% quarter-over-quarter to $3.24B.

Based on Williams Jones & Associates's 13F filing for Q2 2016, filed 15 Aug 2016.